.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Accurate assessment of motor development is critical for diagnosing and managing neurodevelopmental disorders in children and young adults. The newly introduced BOT-3 Movement Fundamentals Score (BOT-3-MFS) provides a streamlined, criterion-referenced measure of foundational motor skills. Recent research has established the psychometric robustness of this tool, making it a valuable addition to the clinical toolkit for pediatricians, neurologists, and psychiatrists in India.
To validate the new scoring system, researchers administered the BOT-3-MFS to a nationally representative sample of 1,360 individuals. The participants ranged in age from 4:0 to 24:11 years. Analysis confirmed that the scores followed expected developmental trajectories, with motor proficiency increasing alongside age. Furthermore, the large sample size ensures that the findings are applicable across a broad demographic spectrum, providing a reliable baseline for clinicians.
The study demonstrated high levels of reliability for the
The research specifically focused on the tool's performance in clinical populations, including individuals with autism spectrum disorder (ASD), developmental coordination disorder (DCD), and developmental delays. Compared to matched controls without motor impairments, all three clinical groups exhibited significantly lower scores (p < .001). This confirms the known-group validity of the assessment. Therefore, the BOT-3-MFS effectively discriminates between typical development and motor impairment, aiding in the early identification of coordination challenges.
The BOT-3-MFS measures foundational motor skills like balance, locomotion, and object control, which are essential for daily living and sports participation.
Yes, the study validated the score for individuals up to nearly 25 years of age, ensuring its utility beyond early childhood.
Because individuals with DCD and ASD typically score significantly lower on the BOT-3-MFS, it serves as an objective indicator of motor impairment during diagnostic evaluations.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A study on 1,360 individuals confirms the BOT-3 Movement Fundamentals Score is a reliable tool for identifying motor impairments in ASD, DCD, and DD groups....
4 months ago
A multi-center study demonstrates that breath aerosol PCR using a specialized face mask collector accurately detects dominant lower respiratory pathogens in pneumonia, achieving 85% concordance with invasive methods and paving the way for rapid, non-invasive microbiological diagnosis.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
